Major Study Shows That Lescol(R) XL, A Statin From Novartis, Improves Post-operative Cardiac Outcomes In Patients Undergoing Vascular Surgery

Patients undergoing vascular surgery treated perioperatively with Lescol® XL (fluvastatin sodium extended-release tablets) showed a significant improvement in postoperative cardiac outcome within 30 days of having the procedure compared with placebo, according to results of the DECREASE (Dutch Ec